Company intelligence / Profile preview

Ecstasy Biotech

Ownership: Private
Development stage: Other

Overview

Ecstasy Biotech is an Indian pharmaceutical and biotechnology company focused on the development, manufacturing, and marketing of a diverse range of therapeutic products. The company's portfolio includes anti-infectives, gastrointestinal treatments, and analgesics, primarily serving the domestic Indian market. Ecstasy Biotech emphasizes quality-driven manufacturing processes to provide affordable healthcare solutions and maintains a presence in both the branded and generic segments of the pharmaceutical industry.

Therapeutic areas: GastroenterologyNeurologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Ecstasy Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ecstasy Biotech.

Explore the full profile